- Home
- THRD vs VMEO Comparison
THRD vs VMEO Comparison
Compare THRD & VMEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- THRD
- VMEO
- Stock Information
- Founded
- THRD 2019
- VMEO 2004
- Country
- THRD United States
- VMEO United States
- Employees
- THRD N/A
- VMEO N/A
- Industry
- THRD Biotechnology: Pharmaceutical Preparations
- VMEO Computer Software: Prepackaged Software
- Sector
- THRD Health Care
- VMEO Technology
- Exchange
- THRD Nasdaq
- VMEO Nasdaq
- Market Cap
- THRD 512.9M
- VMEO 829.0M
- IPO Year
- THRD 2022
- VMEO N/A
- Fundamental
- Price
- THRD $13.11
- VMEO $4.89
- Analyst Decision
- THRD Strong Buy
- VMEO Buy
- Analyst Count
- THRD 3
- VMEO 3
- Target Price
- THRD $20.33
- VMEO $5.33
- AVG Volume (30 Days)
- THRD 156.2K
- VMEO 886.4K
- Earning Date
- THRD 11-07-2024
- VMEO 11-04-2024
- Dividend Yield
- THRD N/A
- VMEO N/A
- EPS Growth
- THRD N/A
- VMEO N/A
- EPS
- THRD N/A
- VMEO 0.19
- Revenue
- THRD N/A
- VMEO $421,083,000.00
- Revenue This Year
- THRD N/A
- VMEO N/A
- Revenue Next Year
- THRD N/A
- VMEO $3.00
- P/E Ratio
- THRD N/A
- VMEO $25.28
- Revenue Growth
- THRD N/A
- VMEO 0.47
- 52 Week Low
- THRD $5.77
- VMEO $3.02
- 52 Week High
- THRD $16.94
- VMEO $5.77
- Technical
- Relative Strength Index (RSI)
- THRD 52.76
- VMEO 47.54
- Support Level
- THRD $11.99
- VMEO $4.75
- Resistance Level
- THRD $13.75
- VMEO $5.06
- Average True Range (ATR)
- THRD 0.83
- VMEO 0.17
- MACD
- THRD 0.02
- VMEO -0.01
- Stochastic Oscillator
- THRD 61.60
- VMEO 37.62
About THRD Third Harmonic Bio Inc.
Third Harmonic Bio Inc is a biopharmaceutical company focused on the development of the next wave of medicine for the treatment of inflammatory diseases, including dermal, respiratory, and gastrointestinal diseases. The company's product candidate, THB001, is a selective, oral small-molecule inhibitor of KIT, a cell surface receptor that serves as the master regulator of mast cell function and survival. Its other product candidate THB335, is a potent, selective, oral small molecule KIT inhibitor, for the treatment of multiple mast cell-driven inflammatory diseases of the skin, airway, and gastrointestinal tract.
About VMEO Vimeo Inc.
Vimeo Inc is the all-in-one video software solution, providing the full breadth of video tools through a software-as-a-service model. Its comprehensive and cloud-based tools empower its users to create, collaborate and communicate with video on a single, turnkey platform. The company derives its revenue from SaaS subscription fees paid by customers for subscription plans.